BPC-157/TB-500 Blend vs Pinealon
Side-by-side comparison of BPC-157/TB-500 Blend and Pinealon: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
BPC-157/TB-500 Blend
Pinealon
BPC-157/TB-500 Blend
Combined healing peptide blend
Lowest listed price: $49.99 across 6 listings
Full BPC-157/TB-500 Blend profilePinealon
Pinealon is a synthetic tripeptide — glutamyl-aspartyl-arginine (Glu-Asp-Arg, or EDR) — developed by the St Petersburg Institute of Bioregulation and Gerontology (IBG) under the leadership of Professor Vladimir…
Lowest listed price: $45.00 across 3 listings
Full Pinealon profileSide-by-side comparison
| Attribute | BPC-157/TB-500 Blend | Pinealon |
|---|---|---|
| Category | Recovery | Nootropics |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | A combination of BPC-157 and TB-500 (thymosin beta-4) in a single formulation. It pairs BPC-157's angiogenic, pro-healing activity - driven largely through VEGFR2 and nitric-oxide (Akt-eNOS) signaling (PMID: 40789979) - with TB-500's actin… | The proposed mechanism of Pinealon is rooted in the Khavinson school's broader theory of short-peptide tissue-specific bioregulation. The full theory is worth understanding because it underlies all twelve Russian bioregulator compounds in this catalog. The… |
| Half-Life | BPC-157: short - under ~30 min in animal PK studies (rats/dogs); no human PK data. TB-500 (thymosin beta-4): active fragment ~30 min, though tissue effects are prolonged. | Not formally characterized in humans. Short regulatory peptides of this class are cleared from plasma within minutes; the Khavinson framework proposes durable downstream gene-expression effects that outlast the brief dosing window, which is the stated rationale for pulsed cycling rather than continuous dosing. |
| Typical Dose Range | Dosed per component (a fixed daily blend over-doses TB-500 - see notes). BPC-157: 250-500 mcg once daily SUBQ. TB-500 (thymosin beta-4): 2-2.5 mg twice weekly during a 4-6 week loading phase, then 2-2.5 mg once weekly for maintenance (~5 mg/week during loading). If a pre-blended fixed-ratio daily vial is used, its TB-500 fraction should be ~250-350 mcg per injection so the weekly TB-500 total stays near ~5 mg. | Subcutaneous (primary route): 2-10 mg/day, typically 3-5 mg, in pulsed 10-20 day cycles, 2-4 cycles/year. Intranasal: 150-800 mcg per nostril daily. Research use only; oral dosing is not recommended because the peptide is largely degraded by GI proteases. |
| Dosing Frequency | BPC-157: once daily SUBQ. TB-500: twice weekly during the loading phase, then maintenance ~2-3x/week or once weekly for TB-500 as needed. | Once daily during a cycle (morning preferred); some advanced users split into AM + midday doses. Not dosed continuously year-round - cycles are pulsed. |
| Administration | Subcutaneous, Intramuscular | — |
| Side Effects | See individual compounds. Generally well-tolerated. Injection site reactions, mild nausea, headache. Rare: temporary fatigue. | The side-effect profile of Pinealon, based on the available Russian clinical literature and user-reported experience, is described as mild and uncommon. Whether this reflects genuinely low toxicity or inadequate reporting in the available studies is a… |
| Molecular Weight | BPC-157: ~1419.5 g/mol (average; molecular formula C62H98N16O22). TB-500 (thymosin beta-4): ~4963 Da (full 43-residue peptide). | 418.40 g/mol (C15H26N6O8) |
| Common Vial Sizes | 5mg, 10mg | — |
Price History
4 data points- OF
- BM
- Half Nattys
- BHG Labs
- RC
Price History
2 data points- Ion Peptide
- Disguised Alpha
BPC-157/TB-500 Blend: potential benefits
- Accelerated tissue healing (preclinical/anecdotal)
- Reduced recovery time
- Anti-inflammatory support
- Complementary repair mechanisms: angiogenesis (BPC-157) plus actin-regulated cell migration (TB-500)
Pinealon: potential benefits
- Neuroprotection against oxidative and hypoxic stress (preclinical models)
- Antioxidant support - reduced oxidative DNA damage in aged neurons (in vitro)
- Cognitive and memory support in aging populations (small Russian clinical reports)
- Reduced neuronal apoptosis and support of dendritic-tree integrity in cell models
- Investigated for neuroprotection in Alzheimer's-model systems (preclinical)
Frequently asked
What's the difference between BPC-157/TB-500 Blend and Pinealon?
BPC-157/TB-500 Blend is a recovery that a combination of bpc-157 and tb-500 (thymosin beta-4) in a single formulation. it pairs bpc-157's angiogenic, pro-healing activity - driven largely through vegfr2 and nitric-oxide…. Pinealon is a nootropics that the proposed mechanism of pinealon is rooted in the khavinson school's broader theory of short-peptide tissue-specific bioregulation. the full theory is worth understanding because…. The two differ in mechanism, half-life (BPC-157: short - under ~30 min in animal PK studies (rats/dogs); no human PK data. TB-500 (thymosin beta-4): active fragment ~30 min, though tissue effects are prolonged. vs Not formally characterized in humans. Short regulatory peptides of this class are cleared from plasma within minutes; the Khavinson framework proposes durable downstream gene-expression effects that outlast the brief dosing window, which is the stated rationale for pulsed cycling rather than continuous dosing.), and typical dose range.
Which has the longer half-life, BPC-157/TB-500 Blend or Pinealon?
BPC-157/TB-500 Blend has a half-life of BPC-157: short - under ~30 min in animal PK studies (rats/dogs); no human PK data. TB-500 (thymosin beta-4): active fragment ~30 min, though tissue effects are prolonged.. Pinealon has a half-life of Not formally characterized in humans. Short regulatory peptides of this class are cleared from plasma within minutes; the Khavinson framework proposes durable downstream gene-expression effects that outlast the brief dosing window, which is the stated rationale for pulsed cycling rather than continuous dosing.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, BPC-157/TB-500 Blend or Pinealon?
Lowest listed price on BodyHackGuide: BPC-157/TB-500 Blend from $49.99, Pinealon from $45.00. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack BPC-157/TB-500 Blend and Pinealon?
Stacking depends on mechanism overlap, safety profile, and goals. BPC-157/TB-500 Blend and Pinealon should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy BPC-157/TB-500 Blend or Pinealon
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.